Hollywood Doctor BUSTED – Shocking Ketamine Pipeline!

May 17, 2026

Medicare card glasses pen money on wooden table

Federal prosecutors say a Hollywood web of doctors, dealers, and “assistants” pushed Matthew Perry ketamine even as his addiction and safety red flags screamed, exposing a drug system that would land any ordinary American in prison far sooner.

Story Snapshot

Federal court records describe a ketamine pipeline to Matthew Perry involving a physician, a street dealer, and a personal assistant.
A former California doctor admitted selling ketamine vials to Perry despite knowing his long addiction history and lack of medical supervision.
Drug Enforcement Administration (DEA) agents say a North Hollywood dealer supplied dozens of ketamine vials tied to Perry’s fatal dose.
The $55,000-in-a-month claim appears in media commentary but is not proven in available court documents or public records.

How Perry’s “Treatment” Slid From Clinic Care Into Criminal Drug Supply

Matthew Perry initially received ketamine in a medical setting, as part of emerging depression treatment that many desperate patients now seek when traditional therapy fails.^[2]^[4] According to the United States Department of Justice, that legitimate care eventually gave way to outright drug distribution. Former physician Salvador Plasencia, who ran a Calabasas clinic, pleaded guilty in federal court to four counts of distributing ketamine and admitted repeatedly supplying vials to Perry outside proper supervision.^[1] That guilty plea draws a hard legal line between real medicine and what prosecutors call trafficking.

The problem was not only that ketamine was present, but how it was delivered. Federal filings state that Plasencia kept selling Perry ketamine even though Perry’s battles with addiction were widely known and documented.^[1] Instead of carefully monitored infusions inside a clinic, Perry’s personal assistant was administering the drug at home without medical training or oversight, according to the Justice Department.^[1] That arrangement would outrage any parent whose child’s doctor handed over powerful anesthetic vials to an untrained friend and walked away.

The Ketamine Network: Doctor, Middleman, Dealer, and an Addicted Celebrity

The Perry case, as laid out by the Justice Department and the Drug Enforcement Administration (DEA), shows how quickly a “gray zone” around controlled substances turns into a criminal pipeline.^[1]^[2] DEA documents describe a North Hollywood drug dealer, Jasveen Sangha, working with a middleman named Erik Fleming to supply ketamine to Perry.^[2] Agents say Sangha sold fifty‑one vials of ketamine to Perry’s circle and was later found with a money counter, scale, packaging materials, and cash, the classic trappings of a street‑level trafficking operation rather than a medical practice.^[2]

Those same DEA records link Sangha to a prior overdose death involving another buyer, showing this was not an isolated lapse but part of a pattern.^[2] Meanwhile, the Justice Department’s account of Plasencia’s conduct underscores that at least one licensed doctor was treated in court as a criminal distributor, not a healer.^[1] Plasencia ultimately surrendered his California medical license after pleading guilty, a step state boards do not take lightly.^[1] For conservatives who have watched the federal government crush small‑town pill mills, the question is why Hollywood’s orbit seemed to enjoy such a long leash before prosecutors finally stepped in.

What We Actually Know About the Money—and What We Do Not

Recent documentaries and social‑media clips repeat a striking claim: that Perry paid roughly fifty‑five thousand dollars in less than a month for ketamine “treatments.” That number is explosive, but the available primary sources tell a more careful story. The Justice Department and Drug Enforcement Administration materials describe repeated vial sales, cash, and trafficking tools, yet they do not publish billing statements, bank records, or a line‑by‑line accounting that proves the exact fifty‑five‑thousand‑dollar figure.^[1]^[2]^[3]

Matthew Perry paid doctors roughly $55,000 in less than a month for ketamine treatments. Investigators later uncovered worrisome text messages.

Watch “Hollywood Demons” Monday on ID and stream on @HBOMax.#HollywoodDemons pic.twitter.com/Wgv0bNbpFQ

— Investigation Discovery (@DiscoveryID) May 16, 2026

As of now, the fifty‑five‑thousand‑dollar claim rests in the realm of commentary, not authenticated court evidence. That does not clear the accused doctors and dealers; it simply means the public record better supports charges of illegal and unsafe distribution than a fully documented profiteering ledger. For readers who care about facts over headlines, this distinction matters. We can say with confidence that a doctor kept selling ketamine despite addiction red flags and no real supervision.^[1] We cannot yet say, backed by records, exactly how much he and others pocketed.

Why This Hollywood Tragedy Should Alarm Ordinary Americans

Conservatives have long warned about two dangerous double standards: one for celebrities and elites, another for everyone else. The Perry case lands squarely in that concern. Federal authorities now acknowledge that Perry’s ketamine use “began legally under a doctor’s supervision” but then slid into unsupervised injections and black‑market sourcing, even as his life history of addiction was common knowledge.^[2]^[3] Yet the full legal hammer only came down after a celebrity death made headlines, not when warning signs first emerged.

For families fighting addiction in small towns, that is an infuriating pattern. Parents watch loved ones locked up quickly for far smaller conduct, while major coastal clinics play games with controlled substances until a famous name dies. The Perry record shows at least one physician selling ketamine vials knowing an untrained assistant would inject them, and a dealer moving dozens of vials through a middleman, all while using cash, money counters, and drug paraphernalia.^[1]^[2] That is not compassionate care; it is a breakdown of professional duty that would be condemned in any other context.

What Needs to Change: Transparency, Equal Justice, and Real Medical Standards

Several reforms flow directly from what we know. First, ketamine clinics offering mental‑health treatments must be forced into sunlight: clear dosing protocols, mandatory in‑clinic administration, and bans on handing vials to untrained assistants would protect patients without outlawing a promising therapy.^[2]^[4] Second, state medical boards and federal regulators should not wait for media outrage. When a doctor admits to repeatedly selling controlled substances to an addicted patient with no supervision, license surrender and criminal referral should follow swiftly, whether the patient is a sitcom star or a steelworker.^[1]

Finally, equal enforcement must be more than a slogan. The same Drug Enforcement Administration that aggressively targets rural pain clinics should treat Hollywood’s boutique “wellness” operations with equal skepticism when they drift into cash‑and‑vial trafficking.^[2] Matthew Perry’s death, as federal authorities now describe it, sprang from a chain of decisions where people who knew better kept pushing drugs anyway.^[1]^[2] Until regulators and prosecutors apply one standard of accountability for the powerful and the powerless alike, tragedies like this will keep repeating—quietly for ordinary families, loudly only when a famous name is involved.